Cytokinetics (CYTK) News Today
No Cytokinetics (CYTK) headline in the last 7 days moved the stock by 0.35% or more. The 1 measured move is in the table below.
Latest headline on this page:
1 headline on Cytokinetics appeared in our news feed in the last 7 days with a measured price reaction attached. The largest measured reaction was 0.00% over 10 minutes on CYTK, after the headline at Oct 12, 16:00:27 ET.
What moved CYTK — last 7 days
| Time | Headline | 1 min | Reaction |
|---|---|---|---|
| Oct 12, 16:00:27 ET | Cytokinetics reported that Phase 3 ACACIA-HCM results indicate aficamten enhances exercise performance in non-obstructive HCM. | 0.00% | 0.00% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 1 minute after they cross the live tape.